5-year IDIQ to provide proteomic services for analysis of clinical samples

Active Indefinite Delivery Contract Awarded

Contract number
75F40125D00022
Awardee
Awarding agency
Task orders
2 $423,150 obligated

Award facts

Combined order value
$423,150 Current and potential, with all options
Last date to order 22% complete
IDV ceiling 21% used
$2,002,500.00
Maximum order
$2,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Food and Drug Administration (FDA) awarded a five-year Indefinite Delivery/Indefinite Quantity contract to Somalogic Operating Co., Inc. (doing business as CM Life Sciences II Inc.) on September 19, 2025, valued at $2,002,500.00 with an ultimate completion date of September 28, 2030. This single-award, non-set-aside contract procures proteomic services for analysis of clinical samples to support the FDA's regulatory science and product evaluation programs. Somalogic will deliver advanced protein measurement and biomarker discovery services utilizing its proprietary SomaScan platform, an aptamer-based assay technology capable of simultaneously measuring up to 11,000 proteins in plasma, serum, and other biological specimens with high sensitivity and reproducibility. The contractor's capabilities span multiple research and regulatory domains including neurodegenerative diseases, cardiovascular health, cancer research, infectious diseases, and immunology, positioning Somalogic as a critical technology partner for the FDA's evaluation of medical product safety and efficacy.

Under this Indefinite Delivery/Indefinite Quantity vehicle, the FDA has already issued a delivery order to Somalogic dated September 23, 2025, for genomic services valued at $269,750.00 with a firm fixed price structure and completion date of September 28, 2026, to be performed in Silver Spring, Maryland. This delivery order represents the initial task order issued against the broader IDIQ contract and reflects the FDA's immediate proteomic analysis needs. Somalogic's established track record with federal agencies, particularly the Department of Health and Human Services entities including the National Institutes of Health and Department of Veterans Affairs, demonstrates proven capability in executing complex proteomic assay services across large-scale clinical research initiatives. The indefinite delivery structure allows the FDA to issue additional task orders as needed throughout the five-year period to support ongoing regulatory science requirements and clinical sample analysis activities.

Task orders

Task order Ordering agency Obligated Awarded
EO 14398 75F40126F19002 Food and Drug Administration $149,500
Genomic services 75F40125F19001 Food and Drug Administration $273,650

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $2,500

Quick answers

Who was awarded contract 75F40125D00022?

75F40125D00022 was awarded to Somalogic Operating Co., Inc. by Food and Drug Administration (Department of Health and Human Services) on September 19, 2025.

How much is contract 75F40125D00022 worth?

Orders under 75F40125D00022 have obligated $423,150. 75F40125D00022's own ceiling is $2,002,500. A single order can be worth up to $2,000,000.

How many orders have been placed under contract 75F40125D00022?

2 orders have been placed under 75F40125D00022, the latest on August 14, 2026.

Who can order from contract 75F40125D00022?

75F40125D00022 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75F40125D00022 competed?

The extent of competition for 75F40125D00022 was not competed. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV